Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Antex Biologics (ANTX) -- Ignore unavailable to you. Want to Upgrade?

To: Vandyman who wrote (1186)	2/10/1999 2:00:00 PM
From: KZAP	Respond to of 1476

Investors are slow in this stock. <g> No hurry. Price will rise tomorrow. Maybe. Good opportunity here. JMO Oops, looks like the last trade was 5/8 and the bid is .69, ask .74. The op is moving away........ KZAP

To: Vandyman who wrote (1186)	2/10/1999 7:23:00 PM
From: Amigo Mike	Read Replies (1) \| Respond to of 1476

Hi Vandy, Very interesting news. The patent award is significant in that it mentions AntexPharma. Now we can look for this side of the business to enter the picture and start developing therapeutics against antibiotic resistant bacteria. I am wondering what's happnin' though. Antex did not release a patent # in the press release I don't yet see this patent awarded. It may show up tomorrow though. In all actuality ..... There is other news on patents also. I do see that Antex was awarded another patent yesterday ..... DIFFERENT from the one listed in the press release. The new patent award pertains to the Campy vaccine. I posted a patent award on Jan 14th that went unannounced that was relevent to Campy. Looks as though this one may go unannounced also. PATENT No: 5869066 ISSUE DATE: Feb-09-1999 Vaccine containing a campylobacter bacterium having an enhanced antigenic property ASSIGNEE: Antex Biologics Inc. Gaithersburg, MD INVENTOR: Pace; John Lee Germantown, MD Walker; Richard Ives Gaithersburg, MD Frey; Steven Michael Germantown, MD OTHER DETAILS: Legal Rep: Pennie Edmonds LLP Application Date: May-30-1997 Application Number: 866592 Primary Examiner: Naff; David M. ABSTRACT: This invention relates generally to in vitro methods for inducing or enhancing expression of enteric bacterial antigens and/or virulence factors thereby producing antigenically enhanced enteric bacteria, to methods for using antigenically enhanced enteric bacteria and to vaccines comprising antigenically enhanced enteric bacteria. Further, a vaccine comprising a Campylobacter bacterium having en enhanced antigenic property is disclosed. The culture medium conditions comprise 0.05% to 3% bile or 0.025% to 0.6% of one or more bile acids or salts. In addition a divalent cation chelator can also be included in the culture medium. The bacteria culture is in a growth phase at early log phase and between early log phase and stationary phase. The enhanced antigenic property is a higher level of an immunogenic antigen when compared to the antigenic property of the same bacteria grown on brain heart infusion broth. Amigo Mike